Agilent
Agilent Q2 Revenues Rise 23 Percent
The company's revenues rose to $1.53 billion from $1.24 billion and beat the analysts' average estimate of $1.40 billion.
Molecular Assemblies Extends Series A Financing Round by $11.8M
The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund.
The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark.
Agilent, Oxford BioDynamics Sign Supply, Resale Agreement for Array Kit
Agilent will supply a custom-made SurePrint G3CGH Microarray for Oxford's newly launched Explorer Array Kit, which will include OBD's 3D Genome Probes.
Mar 9, 2021
Agilent Receives CE Mark for SARS-CoV-2 PCR Test
Mar 4, 2021
Mar 4, 2021
Agilent Prices $850M Senior Notes Offering
Nov 23, 2020
Agilent Q4 Revenues Rise 8 Percent
Aug 18, 2020
Agilent Q3 Revenues Drop 1 Percent
Aug 17, 2020
Mobilion Closes $35M Series B Funding Round
Jun 12, 2020
May 21, 2020